38.45
38.45 (0%)
As of May 29, 2025
Praxis Precision Medicines, Inc. [PRAX]
Source:
Company Overview
Praxis Precision Medicines, Inc is a clinical-stage biopharmaceutical company translating insights from genetic epilepsies into the development of therapies for central nervous system, or CNS, disorders characterized by neuronal excitation-inhibition imbalance.
Country | United States |
Headquarters | boston, massachusetts |
Phone Number | 617-300-8460 |
Industry | manufacturing |
CEO | Marcio Souza |
Website | clinicaltrials.gov |